Extended spectrum B-lactamases in urinary isolates of escherichia coli in five Iranian hospitals

Asian Journal of Pharmaceutical and Clinical Research

Volumn 5, Issue SUPPL 2, 2012, Pages 35-36

  Mobaleghi, Jafar ^a   Salimizand, Heiman ^a   Beiranvand, Soheila ^a   Membari, Shaho ^a   Kalantar, Enayat ^a,b  

^a KURDISTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ALBORZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Antimicrobial resistance; E. coli; Kurdistan; Urinary tract infection

Indexed keywords

AMIKACIN; AMOXICILLIN; AMPICILLIN; CEFOTAXIME; CHLORAMPHENICOL; CIPROFLOXACIN; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; PENICILLIN G; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; DISK DIFFUSION; ESCHERICHIA COLI; IRAN; NONHUMAN; URINALYSIS; URINARY TRACT INFECTION;

EID: 84862746532     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Ronald A.R., Nicolle, L.E., Stamm E. Urinary tract infection in adults: research priorities and strategies. Int. J. Antimicrob. Agents 2001;17:343-8.
2. Van Eldere, J. Multicentre surveillance of Pseudomonas aeruginosa susceptibility patterns in nosocomial infections. J. Antimicrob. Chemother. 2003; 51(2):347-352.
3. Miranda S, Davide M, Peter J. Evolution of multi-resistance plasmids in Australia clinical isolates of Escherichia coli. Microbiology. 2004;150: 1539-1546.
4. Hassan S. Sensitivity of Salmonella and Shigella to antibiotics and chemotherapeutic agents in Sudan. J. Trop. Med. Hyg.1995; 88: 243-248.
5. Pitout, J. D., P. Nordmann, K. B. Laupland, and L. Poirel. Emergence of Enterobacteriaceae producing extended-spectrum β-lactamases (ESBLs) in the community. J. Antimicrob. Chemother. 2005;56:52-59.
6. Astal Z, Sharif FA, Abdallah SA, Fahd MI. Extended spectrum beta-lactamases in E. coli isolated from community-acquired urinary tract infections in the Gaza Strip, Palestine. Ann Saudi Med. 2004;24: 55-57.
7. World Health Organization Anti-tuberculosis drug resistance in the world. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance 1994-1997. WHO/TB/97-229. Geneva: The Organization; 1997.
8. O'Brien T. The global epidemic nature of antimicrobial resistance and the need to monitor and manage it locally. Clinical infectious diseases. 1997; 24 (suppl. 1): S2-S8.
9. Mackie and Mc Cartney. Practical Medical Microbiology, 2007; 13th edition; p. 171-172.
10. Clinical and Laboratory Standards Institute: 2010. Performance standards for antimicrobial susceptibility testing; 20th informational supplement. CLSI/NCCLS M100-S20. 3 (1): Clinical and Laboratory Standards Institute, Wayne, Pa.
11. Babypadmini S, Appalaraju B. Extended spectrum β-lactamases in urinary isolates of Escherichia coli and Klebsiella pneumoniae-prevalence and susceptibility pattern in a tertiary care hospital. Indian Journal of Medical Microbiology. 2004; 22 (3):172-174.
12. Odusanya O. Antibiotic susceptibility of microorganisms at a general hospital in Lagos, Nigeria. Journal of the National Medical Association. 2002;49(11): 994-998.
13. Umolu P. Idia, Omigie O., Tatfeng Y., Omorogbe F.I., Aisabokhale F, Ugbodagah O. P. Antimicrobial Susceptibility and Plasmid Profiles of Escherichia coli Isolates Obtained from Different Human Clinical Specimens in Lagos-Nigeria. Journal of American Science. 2006;2(4):70-75.
14. Ava Behrooozi, Mohammad Rahbar and Jalil Vand Yousefi. Frequency of extended spectrum beta-lactamase (ESBLs) producing Escherichia coli and Klebseilla pneumonia isolated from urine in an Iranian 1000-bed tertiary care hospital. 2010. African Journal of Microbiology Research. 2010; 4 (9): 881-884.
15. Mohamudha P, Subha Manivannan, Harish B, Parija C. Study of CTX-M Type of Extended Spectrum b-Lactamase among Nosocomial Isolates of Escherichia coli and Klebsiella pneumoniae in South India. Indian J Microbiol. 2011; DOI 10.1007/s12088-011-0140-3.